Zimmer NexGen Knee Lawsuits to be Selected for First Case Picks in MDL

Following a status conference held earlier this month in the federal multidistrict litigation (MDL) established for all Zimmer NexGen knee replacement lawsuits, the parties have been directed to submit their case picks for the first trial dates by February 7, 2014.

There are currently nearly 1,200 product liability lawsuits filed in U.S. District Courts throughout the country that have been consolidated for pretrial proceedings before U.S. District Judge Rebecca R. Pallmeyer in the Northern District of Illinois, where a small group of cases are being prepared for early trial dates, known as “bellwether” cases.

Pursuant to a prior case management order issued last year, which outlined the process for preparing the first Zimmer NexGen knee cases for a series of test trials, case-specific discovery has been on-going over the past six months.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

According to the minutes (PDF) from a status conference held before Judge Pallmeyer on January 17, the parties have been ordered to submit their recommended “case pool picks” by February 7, with each side filing a response to the selections by February 28, 2014.

The next status conference in the Zimmer NexGen MDL is scheduled for March 21, 2014, with additional conference dates set through the remainder of the year for May 16, July 18, September 19 and November 21, 2014. Judge Pallmeyer previously indicated that the first cases will be trial ready by January 2015.

The preparation and outcome of these early trial dates are designed to help the parties gauge how juries are likely to respond to certain evidence and testimony that may be repeated throughout the litigation.

All of the complaints involve similar allegations that certain configurations of the Zimmer NexGen artificial knee system are defective and prone to fail within a few years. Plaintiffs claim that they experienced problems with various Zimmer knee replacements, including the Zimmer NexGen LPS-Flex, Zimmer NexGen CR-Flex, Zimmer NexGen GSF LPS-Flex, Zimmer NexGen GSF CR-Flex and Zimmer NexGen MIS Tibia component.

Following the bellwether trials in the MDL, if a Zimmer NexGen knee settlement agreement or other resolution for the litigation is not reached, hundreds of cases could be remanded back to U.S. District Courts throughout the country for individual trial dates.

1 Comments

  • Sarah FJanuary 13, 2017 at 7:17 am

    I had a recalled knee revision I was with Anapol and Schwartz. my 1st knee 2009 I was told in beginning I met all requirements. My case was declined because a Dr wrote posible infection , no positive pathology. I after this time suffer so much my life is terrible as result. Don't I have any alternative

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Generic Depo-Provera Manufacturers Call for Birth Control Shot MDL to Be Created in NY, Not California
Generic Depo-Provera Manufacturers Call for Birth Control Shot MDL to Be Created in NY, Not California (Posted 2 days ago)

A growing number of lawsuits against generic Depo-Provera manufacturers have been filed throughout the federal court system, each alleging that women were not adequately warned about the risk of meningioma brain tumors from the birth control shot.

Oxbryta Class Action Lawsuit Filed by Former Users of Sickle Cell Disease Drug Recalled in 2024
Oxbryta Class Action Lawsuit Filed by Former Users of Sickle Cell Disease Drug Recalled in 2024 (Posted 3 days ago)

Former users of the recalled sickle cell disease drug Oxbryta have filed a class action lawsuit, claiming the manufacturer failed to warn consumers about risks associated with the medication, which can result in stroke and death.

Group of 20 Uber Driver Sexual Assault Lawsuits Will Be Prepared for Bellwether Trials in Dec. 2025
Group of 20 Uber Driver Sexual Assault Lawsuits Will Be Prepared for Bellwether Trials in Dec. 2025 (Posted 3 days ago)

Plaintiffs and defendants have each been directed to select 10 Uber driver sexual assault lawsuits to serve as potential bellwether trials by February 14, 2025, which will then go through case-specific discovery to prepare for early test trials.